When considering melanoma, patients with higher CD8a expression have demonstrated improved survival; however, patients with lung adenocarcinoma show no significant difference in survival based on CD8a expression levels (Supplemental Figure 1D). This evidence concerns the gene CD8A and lung adenocarcinoma.